[Histological and cytopathological cancer specimens: good practice in operating room].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 14659622)

Published in Ann Chir on November 01, 2003

Authors

L Benoit1, P Favoulet, F Collin, L Arnould, J Fraisse, J Cuisenier

Author Affiliations

1: Service de chirurgie, centre G.-F.-Leclerc, 1, rue du Professeur-Marion, BP 77980, 21079 Dijon cedex, France. lbenoit@dijon.fnclcc.fr

Articles by these authors

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol (1997) 3.60

Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res (2000) 3.06

Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer (2001) 2.85

Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol (1996) 2.53

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol (2005) 2.39

Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer (1999) 2.29

Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol (2001) 2.29

Smoking-attributable medical care costs in the USA. Soc Sci Med (1999) 2.26

Experimental design and low-level analysis of microarray data. Int Rev Neurobiol (2004) 1.73

Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes? Trans R Soc Trop Med Hyg (2011) 1.50

Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs. HIV Med (2007) 1.40

The cost of health conditions in a health maintenance organization. Med Care Res Rev (2000) 1.40

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study. Histopathology (2003) 1.23

Malignant extraovarian endometriosis: a review. Eur J Surg Oncol (2005) 1.23

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clin Exp Immunol (2007) 1.20

Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone (2005) 1.20

Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer (1994) 1.17

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Br J Cancer (2010) 1.14

T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival. Br J Cancer (2011) 1.14

Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol (2001) 1.12

Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer (1996) 1.12

CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am J Surg Pathol (1999) 1.10

Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor. Am J Surg Pathol (1997) 1.10

Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest (1999) 1.07

Demographic characteristics and opportunistic diseases associated with attrition during preparation for antiretroviral therapy in primary health centres in Kibera, Kenya. Trop Med Int Health (2011) 1.07

A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol (2009) 1.06

Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg (2010) 1.05

[Partial monosomy 20q: a new syndrome. Regional assignment of the adenosine deaminase (ADA) locus on 20q132 (author's transl)]. Ann Genet (1981) 1.03

[Laënnec, re-inventor of the stethoscope?]. Presse Med (1998) 1.02

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study. Br J Cancer (2012) 1.01

Regional assignment of the ADA locus on 20q13.2 leads to qter by gene dosage studies. Cytogenet Cell Genet (1980) 1.01

Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. Ann Oncol (2012) 0.99

[How to classify a soft tissue sarcoma in 2006]. Ann Pathol (2006) 0.98

[A second example of telomeric fusion 2 X chromosomes]. Ann Genet (1975) 0.97

[Metastatic renal cell carcinoma to the thyroid gland: report of seven cases and review of the literature]. Ann Chir (2004) 0.96

Concurrent lymphoma and metastatic breast carcinoma in the axillary, confounding sentinel lymph-node biopsy. Eur J Surg Oncol (2004) 0.94

Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma. Br J Cancer (2009) 0.94

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol (2008) 0.94

Non-Hodgkin's lymphoma of the urethra: a rare extranodal entity. Gynecol Oncol (1989) 0.93

Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. Cancer Genet Cytogenet (1993) 0.93

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients. Br J Cancer (2013) 0.92

Traumatic rupture of the pericardium with intermittent cardiac herniation in a multiple-trauma patient. Acute Care (1987) 0.92

Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study. Qual Life Res (2012) 0.91

[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]. Ann Pathol (1996) 0.91

[The association of uterine lipoma and cancer of the endometrium. Diagnostic and etiopathogenic approach]. J Gynecol Obstet Biol Reprod (Paris) (1990) 0.91

FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial. Ann Oncol (2012) 0.90

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer. Br J Cancer (2010) 0.88

[Multiple paragangliomas of the neck localized in the thyroid region. Papillary thyroid cancer associated with parathyroid adenoma]. Sem Hop (1982) 0.87

Two molecular forms of gonadotropin-releasing hormone from the brain of the frog, Rana ribibunda: purification, characterization, and distribution. Endocrinology (1993) 0.87

EBV-positive Burkitt's lymphoma from Algeria, with a three-way rearrangement involving chromosomes 2, 8 and 9. Int J Cancer (1981) 0.86

Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J Comp Neurol (1996) 0.86

The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol (2005) 0.86

Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae. Verh Dtsch Ges Pathol (1998) 0.85

Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy. Ann Oncol (2010) 0.85

Retroperitoneal extra-adrenal myelolipoma: appearance in CT and MRI. Diagn Interv Imaging (2012) 0.85

Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats. Clin Exp Metastasis (1999) 0.84

Six cases of partial duplication-deficiency 21 syndrome: 21(dupq22delp23) due to maternal pericentric inversion: inv(21)(p12;q22). A family study. Ann Genet (1986) 0.84

[Xeroderma pigmentosum and long-term treatment with an aromatic retinoid. Preventive effect on epitheliomatous degeneration?]. Ann Dermatol Venereol (1982) 0.84

Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation? Liver Transpl Surg (1998) 0.83

Early incidence of adriamycin treatment on cardiac parameters in the rat. Can J Physiol Pharmacol (1994) 0.83

Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Ann Oncol (2009) 0.83

Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy. Cancer Res (1995) 0.83

Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer. Dis Markers (1999) 0.83

[Use of urapidil during surgery for pheochromocytoma]. Ann Fr Anesth Reanim (1996) 0.83

Report of a primary lymphoma of the conjunctiva. A lymphoma of MALT origin? Pathol Res Pract (1991) 0.83

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'. Ann Oncol (2011) 0.82

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study. Am J Pathol (1997) 0.82

[Two new cases of trisomy 10q21 to 10qter in two sisters due to paternal translocation t(9;10) (q34;q24)]. Ann Genet (1977) 0.82

[A case of annular chromosome 9. Indentification by controlled denaturation]. Ann Genet (1974) 0.82

[Partial monosomy 20q : a new syndrome. Regional assignment of the ADA locus on 20q132 (author's transl)]. Sem Hop (1982) 0.82

Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation. Blood (1988) 0.82

Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. Anticancer Res (1998) 0.81

Genital carcinoma secondary to pagetoid spread from a pagetoid urothelial carcinoma in-situ. Histopathology (1998) 0.81

Microstructural factors controlling the survival of food-borne pathogens in porous media. Int J Food Microbiol (2001) 0.81

Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma. J Clin Oncol (1987) 0.81

A desmoid tumour associated with a breast prosthesis. Diagn Interv Imaging (2012) 0.80

Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection. Brain Res (1998) 0.80

[Malignant tumours arising in extraovarian endometriosis: three case reports and review of the literature]. Ann Chir (2004) 0.80

[Standards, options and recommendations for the practice of oncologic surgery. National Federation of Centers for the Fight against Cancer]. Bull Cancer (1995) 0.80